“Pakistan — a key U.S. ally in global efforts to combat Islamist militancy — is in urgent need of an estimated $4 billion in capital to avoid defaulting on its sovereign debt.” See “Pakistan’s Capital Crisis: Implications for U.S. Policy” (pdf), Congressional Research Service, November 7, 2008.
A new Pentagon manual (pdf) issued by Under Secretary of Defense (Intelligence) James R. Clapper prescribes the implementation of the Department of Defense operations security (OPSEC) program. OPSEC is the process of identifying sensitive information that could be exposed to hostile detection in the course of military operations, and taking steps to protect such information. See “DoD Operations Security (OPSEC) Program Manual,” DoD Manual 5205.02M, November 3, 2008.
The state of national preparedness for a bioterrorist incident was examined last year in a newly published congressional hearing, which includes supplementary questions and answers for the record. See “Six Years After Anthrax: Are We Better Prepared to Respond to Bioterrorism?”, Senate Committee on Homeland Security and Governmental Affairs, October 23, 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.